Copanlisib hydrochloride
Copanlisib hydrochloride | |
---|---|
Term | Copanlisib hydrochloride |
Short definition | copanlisib hydrochloride - (pronounced) (koh-PAN-lih-sib HY-droh-KLOR-ide) drug used to treat adults with follicular lymphoma that has come back after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
copanlisib hydrochloride - (pronounced) (koh-PAN-lih-sib HY-droh-KLOR-ide) drug used to treat adults with follicular lymphoma that has come back after treatment with at least two other systemic therapies. It is also being studied in the treatment of other types of cancer. Copanlisib hydrochloride blocks certain proteins that can help stop cancer cells from growing and kill them. It's a kind of kinase inhibitor. Also called Aliqopa
External links
- Medical encyclopedia article on Copanlisib hydrochloride
- Wikipedia's article - Copanlisib hydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski